-
NPR's Scott Simon speaks to Arshad Malik, Afghanistan country director for Save the Children, about the aftermath of the deadly floods that hit several provinces there last weekend.
-
Boeing held its annual shareholders meeting on Friday. This follows a difficult week and year for the plane-maker, which is facing renewed scrutiny over its safety and production practices.
-
NPR's Scott Simon talks with strategic studies professor Phillips O'Brien of the University of St. Andrews in Scotland about the significance of Russia's latest military offensive in Ukraine.
-
A flag flap for a Supreme Court justice, and both major presidential campaigns agree to debates, albeit earlier than is traditional, with some rule changes.
-
The U.S. military says the first shipment of aid has moved ashore into Gaza over a new, massive floating pier. It wants to scale up to 150 trucks entering Gaza per day.
-
There's a lot of finger-pointing in Slovakia following the assassination attempt this week on its prime minister. It's another example of political violence that's been taking place in Europe of late.
-
A Crimean Tatar couple in Ukraine, displaced by Russian troops, sees parallels to the Soviets' forced deportation of 200,000 Tatars from Crimea 80 years ago.
-
Today is the Preakness Stakes, the 2nd leg of horse racing's Triple Crown. NPR's Scott Simon talks to Jonathan Finn, author of "Beyond the Finish Line," about the history and tech of photo finishes.
-
A reluctant hero's quest, a can-do princess, and an evil wizard who just can not shut up: NPR's Scott Simon talks with Peter S. Beagle about his new novel, "I'm Afraid You've Got Dragons."
-
Mercedes-Benz workers voted against union representation in Alabama, a defeat for the United Auto Workers.
-
NPR's Scott Simon talks to Matt Shultz, frontman for the band Cage the Elephant, about reassessing one's reality and his band's new album, "Neon Pill".
-
Skin cancer is the most common cancer in the U.S. and we need all the protection we can get. So why is it so hard to get newer, more effective ingredients approved here?